Last reviewed · How we verify
CNF2024
At a glance
| Generic name | CNF2024 |
|---|---|
| Also known as | BIIB021, Advanced Solid Tumors |
| Sponsor | Biogen |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CNF2024 CI brief — competitive landscape report
- CNF2024 updates RSS · CI watch RSS
- Biogen portfolio CI